DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20160748

To study the efficacy and tolerability of fenugreek seed powder as add-on therapy with metformin in patients of type-2 diabetes mellitus

Manmeet Kaur, Narinder Singh, Geeta Sharma, Davinder Singh

Abstract


Background: Fenugreek, an ancient herb has been known for its culinary and medicinal value in Indian Subcontinent. Its seeds, rich in fibers and phytochemical compounds, have been investigated for their hypoglycemic and multiple benefits. This study was thus undertaken to assess the anti-hyperglycemic effect of fenugreek seeds in patients of Type 2 Diabetes Mellitus (DM) as add-on therapy with metformin.

Methods: An open-labelled comparative study of 12 weeks duration was conducted on patients (randomly divided in 2 groups of 30 each) of Type 2 DM. Group 1 was given metformin 500 mg twice a day while group 2 was given 500 mg of metformin along with fenugreek seed powder capsule,1 gm thrice a day. Weekly evaluation for fasting and post-prandial blood sugar was done. HbA1c estimation was done at the beginning and at the end of the study. Student’s t-test (paired and unpaired) was applied for statistical analysis.

Results: After 12 weeks of treatment, there was significant fall in fasting, as well as postprandial blood sugar and HbA1c levels in group 1 and group 2. However this improvement was statistically more significant in group 2 when compared to group 1.

Conclusions: This study shows the beneficial effects of fenugreek seeds on glycemic profile in patients of Type 2 DM and can be used as an add-on therapy with metformin in management of Type 2 DM.


Keywords


Type 2 Diabetes Mellitus (DM), Fenugreek

Full Text:

PDF

References


Powers AC. Diabetes Mellitus. In: Fauci AS, Braunwald E, Kasper DL, Stephen LH, Dan LL, Jameson JL, LoscalzoJ, editors .Harrison’s Principles of Internal Medicine. 18thed. New York: McGraw Hill. 2012:2968-3002.

American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2012;35(1):65-71.

American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2013;36(1):1-114.

Martha M, Kennedy N. Pancreatic hormone and anti-diabetic drugs. In: Katzung BG, Masters SB, Trevor AI, editors. Basic and Clinical Pharmacology. 12thed. New Delhi: Tata McGraw Hill. 2012:753-67.

Management of Diabetes. A national clinical guideline. Edinburgh; Scottish Intercollegiate Guideline Network: 2010:10-50. Available from:www.sign.ac.uk/guidelines/fulltext/50/index. html.

Olefsky JM. Insulin resistance and pathogenesis of non-insulin dependent diabetes mellitus: cellular and molecular mechanisms. In: Efendic S, Ostens on CG, Vranic M, editors. New concept in the Pathogenesis of NIDDM. New York: Plenum Publishing Corporation. 1999.

Davidson MB, Diabetes Mellitus: Diagnosis and Treatment. 21 New York, NY. Churchill Livingstone. 2010:795-835.

Ansari R, Ansari S. Effectiveness of fenugreek for lowering the hemoglobin (HbA1c) in the patients with self-management of type 2 diabetes: A Randomized Control Trial. Medical Complication of Type-2 Diabetes. Dr. Collen Croniger (Ed). 2011. SBN; 978-953-307-367.InTech.Available from:http: //www.intechopen. com/books/medical- complications-of-type-2-diabetes/effectiveness-of-fenugreek-for-loweriong-haemoglobin-hba1c-inpatients-with-self-management-of-type-2-diabeteS

Morcos SR, Elhawary Z, Gabrial GN. Protein rich food mixtures for feeding the young in Egypt. Z Ernahrungswiss. 1981;20:275-82.

Kumar VS, Rama Rao DKA, Mohanty S. Comparative study of fenugreek seeds on glycemic index in high and medium dietary fibre containing diets in NIDDM Patients. NJIRM. 2011;2(3):29-37.

Neelkantan N, Naranyanan M, J de Souza R, van Dam RM. Effect of fenugreek (Trigonella foenum-graceum L.) intake of glycemia:a meta-analysis of clinical trials . Nutritional J. 2014;13;1-11.

Buse JB, Polonsky KS, Burant CF. Type 2 Diabetes Mellitus. In: Melmed S, Polonsky KSN, Larsen PR, Kronenber HM, editors. Williams Book on Endocrinology. 12TH ed. New Delhi. Elsevier Saunders: 2012:1371-1434.

Valliyot B, Sreedharan J, Muttappallymyalil J, Valliyot SB. Risk factors of type 2 diabetes mellitus in the rural population of north kerala, india: a case control study. Diabetologia Croatica. 2013;42(1):33-40.

Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids. 1997;56(5):379-84.

Lu FR , Shen L, Qin Y, Gao L, Li H, Dai Y. Clinical observation on trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus. Chin J Integr Med. 2008;14(1):56-60.

Gupta A, Gupta B, Lal B. Effect of Tigonella foenum-graceum (fenugreek) seeds on the glycemic control and insulin resistance in type 2 diabetes mellitus:a double blind placebo controlled study. J Assoc Physicians India. 2001;49;1057-61.

Vijayakumar MV, Singh S, Chhipa RR, Bhat MK. The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway. British Journal of Pharmacology. 2005;146(1):41-8.

Ramesh Babu K, Yogesh, Raghvendra HL, Kantikar SM, Prakash KB. Antidiabetic and histopathological analysis of fenugreek extract and alloxan induced diabetic rats. Int J Drug Dev& Res. 2010;2(2):356-64.

Muraki E, Hayashi Y, Chiba H, Tsunoda N, Kasono K. Dose-dependent effects, safety and tolerability of fenugreek in diet-induced metabolic disorders in rats. Lipids Health Dis. 2011;10:240.

Puri D, Prabhu KM, Murthy PS. Mechanism of action of a hypoglycemic principle isolated from fenugreek seeds. Indian J Physiol Pharmacol. 2002;46(4):457-62.

Haeri MR, Limaki HK, White CJ, White KN. Non-insulin dependent anti-diabetic activity of (2S, 3R, 4S) 4-hydroxyisoleucine of fenugreek (Trigonella foenum graecum) in streptozotocin-induced type I diabetic rats. Phytomedicine. 2012;15;19(7):571-4.

Sauvaire Y, Petit P, Broca C, Manteghetti M, Baissac Y, Fernandez-Alvarez Jl. Hydroxyleucine, a novel potentiator of insulin secretion. Diabetes. 1998;47(2):206-10.

Ribes G, Sauvaire Y, Da Costa C, Baccou JC, Loubatieres-Mariani MM. Antidiabetic effects of subfractions from fenugreek seeds in diabetic dogs. Proc Soc Exp Biol Med. 1986;182(2):159-66.